ArticleScientific reports2026
N
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral cancer is a major public health concern in South Asia, particularly in Pakistan, India, and Bangladesh, largely due to the widespread use of smokeless tobacco (SLT) products. The World Health Organization (WHO) classifies SLT as a Group 1 carcinogen. These products contain glycotoxins, such as methylglyoxal (MGO) that is well-known to cause genotoxicity by reacting with DNA. One of the most stable MGO-derived DNA adducts is N2-(1-carboxyethyl)-2′-deoxyguanosine (CEdG), which has been reported to cause DNA damage and genetic instability. However, the role of CEdG in the pathogenesis of oral cancer remains unstudied, and the MGO content in various SLT has not been previously determined. To our knowledge, this study represents one of the first investigations into the abundance of CEdG in oral cancer and its association with chromatin organization, while also quantifying MGO levels in SLT. CEdG was detected using a semi-quantitative in situ immunofluorescence assay and correlated with chromatin computational morphometry to evaluate CEdG-associated alterations in chromatin organization. Using ELISA, we also assessed MGO levels in various SLT, revealing elevated concentrations in commonly used products such as gutka, naswar, and khaini. Our results demonstrated significantly higher levels of CEdG in cancerous nuclei and were strongly correlated with disorganized chromatin texture. Together, these findings suggest that exposure to MGO-rich SLT is associated with CEdG accumulation and subsequent chromatin disorganization, which may be relevant to tobacco-associated oral carcinogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.